20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Steroid-Induced Ocular Hypertension: Exploring Treatments and the Role of Pharmaceutical Compounds

Steroid-induced ocular hypertension (OHT) is a condition where the use of corticosteroids leads to an elevation in intraocular pressure (IOP). Managing this condition is crucial to prevent glaucomatous damage. Pharmaceutical intermediates that contribute to the development of novel treatments for OHT are of significant interest. Anecortave Acetate, a compound investigated for its effects on IOP, including in cases of steroid-induced OHT, represents one such area of research. The study of anecortave acetate for glaucoma treatment has provided insights into potential therapeutic strategies.

The research into anecortave acetate and steroid-induced OHT has focused on its ability to modulate IOP, potentially by affecting aqueous outflow facility. Understanding the anecortave acetate mechanism of action in this context is vital for developing more targeted treatments. The use of specific drug delivery systems, such as the juxtascleral depot, was explored to achieve sustained control of IOP. While Anecortave Acetate itself may not be a widely used treatment today, the knowledge gained from these investigations is invaluable. Pharmaceutical intermediates are the essential starting materials for synthesizing these complex molecules. NINGBO INNO PHARMCHEM CO.,LTD. ensures the availability of high-quality intermediates, supporting the ongoing research and development efforts aimed at effectively managing steroid-induced ocular hypertension and other forms of glaucoma. Our commitment to quality empowers scientific progress in creating safer and more effective ocular therapies.

The ongoing quest for better treatments for steroid-induced ocular hypertension relies on the availability of advanced pharmaceutical compounds and innovative delivery systems. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a supplier of critical pharmaceutical intermediates that facilitate this vital research and development.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Pharmaceutical Journey of Anecortave Acetate: From Research to Clinical Trials and Beyond

Next: The Truth About Tanning Peptides: What Influencers Aren't Telling You

All Rights Reserved